Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Iovance Biotherapeutics, Inc. 401(K) Plan is a benefit plan reported by Iovance Biotherapeutics, Inc. under EIN 75-3254381 and plan number 001. The latest loaded filing year is 2023. The filing reports 586 participants and $42,588,709 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $42,588,709
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $42,588,709
- Net assets (BOY)
- $25,667,518
Income & contributions
- Employer contributions
- $4,031,098
- Participant contributions
- $8,359,487
- Total contributions
- $13,319,210
- Total income / additions
- $19,387,899
Expenses & distributions
- Benefits paid
- $2,354,630
- Administrative expenses
- $94,745
- Total expenses
- $2,466,708
- Net increase / (decrease)
- $16,921,191